Of three patients who had undergone this operation before the use of this monitoring technique, one had an unrecognized late graft failure.
The frequency of the use of this monitoring function is at the discretion of the participant.
Third, as with all observational studies, we can only hypothesize that patient management could be improved by the clinical use of this monitoring tool.
However, the context surrounding use of this invasive monitoring system has evolved over the past decade.
This precludes the use of these monitors for monitoring or titrating sedation in the critically ill.
Because use of these monitors is so common, efforts to ensure their accuracy are important.
Williams et al. (2009) have previously described in detail the use and modification of this monitor in DEARS.
Secondly, we will focus on the use of this approach to monitor translational activation and repression in Xenopus oocytes, giving a detailed protocol, and discussing possible optimizations we have explored.
This also limits the potential use of this biosensor to monitor the kinetics and dynamics of the DNA surface hybridization.
Many of the genes found to have been differentially expressed by RNA-seq have previously been determined to be members of the Neisserial FNR or NsrR regulons, validating the use of this technique to monitor transcriptome changes (Table 1) [ 3, 7, 18, 19].
